港股早評:三大指數低開 科技股多數下跌 寧德時代開升2.6%再創新高
特朗普持續發出關税威脅,隔夜美股三大指數集體上升,中概指數跌1.11%。港股三大指數低開,恒指跌0.11%,國指跌0.1%,恒生科技指數跌0.26%。盤面上,大型科技股多數下跌,網易跌2%,京東、美團跌1%,阿里巴巴、百度跌0.8%,小米、快手飄紅;茶飲料概念股普遍下跌,茶百道、蜜雪集團跌2%,有色金屬股、軟件類股、生物醫藥股多數走低,昨日飆升翻倍的巨星傳奇跌超3%。另一方面,蘋果概念股走高,舜宇光學升3.5%,創新藥概念股多數繼續活躍,君實生物、百濟神州升超2%,寧德時代高開2.6%再創新高。(格隆匯)
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.